Japan
It plans to develop an in-house cloud platform.
The company aims to help the self-testing market grow by licensing its core technology for transforming smartphones into IVD devices.
Its web-based platform also guides patients to access appropriate medical care.
A clinical trial has shown that it can predict AD progression with 88% and 84% accuracy in American and Japanese patients, respectively.
Also, Terumo has partnered with Glooko to enable diabetes data transfer from insulin patch pump to a data platform.
As part of the agreement, SoftBank will research market opportunities for the digital therapeutic, and it can negotiate an exclusive commercialization deal in Japan.
Also, MedLern announces a partnership to help train emergency nurses in India in trauma nursing.
The use of social skill training VR facilitates the social rehabilitation of patients with mental disorders.
The research targets people with complex regional pain syndrome, post-stroke pain, and other pain-induced conditions.
This will provide doctors with timely access to patients' health records.